| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Barclays analyst Andrew Mok maintains Encompass Health (NYSE:EHC) with a Overweight and raises the price target from $141 to...
Encompass Health (NYSE:EHC) raises FY2025 Adj EPS guidance from $5.12-$5.34 to $5.22-$5.37 vs $5.28 analyst estimate. Narrows F...
Encompass Health (NYSE:EHC) reported quarterly earnings of $1.23 per share which beat the analyst consensus estimate of $1.20 b...
A powerful surge in AI-related stocks — led by a 9% advance in NVIDIA Corp. (NASDAQ:NVDA) over the past two sessions — propelle...